Icon PLC (ICLR) came out with quarterly earnings of $3.26 per share, beating the Zacks Consensus Estimate of $3.18 per share. This compares to earnings of $3.75 per share a year ago. These figures are ...

Icon PLC (ICLR) is expected to deliver a year-over-year decline in earnings on lower revenues when it reports results for the quarter ended September 2025. This widely-known consensus outlook gives a ...

A month has gone by since the last earnings report for Icon PLC (ICLR). Shares have lost about 8.9% in that time frame, underperforming the S&P 500. Will the recent negative trend continue leading up ...

ICON plc reported better-than-expected earnings for the second quarter of 2025, with earnings per share (EPS) of $3.26, surpassing the forecast of $3.19. This positive surprise, combined with revenue ...

Icon PLC (ICLR) came out with quarterly earnings of $3 per share, beating the Zacks Consensus Estimate of $2.93 per share. This compares to earnings of $2.55 per share a year ago. These figures are ...

DUBLIN 18, Ireland (AP) — Icon PLC (ICLR) on Wednesday reported third-quarter profit of $2.4 million. The Dublin 18, Ireland-based company said it had profit of 3 cents per share. Earnings, adjusted ...

Icon PLC (ICLR) came out with quarterly earnings of $2.63 per share, in line with the Zacks Consensus Estimate. This compares to earnings of $1.90 per share a year ago. These figures are adjusted for ...

ICON plc, (NASDAQ: ICLR) a world-leading healthcare intelligence and clinical research organisation, has been honoured in the first half of 2025 with a number of business awards, recognising the ...

Net business wins in the quarter of $2,022 million; a net book to bill in the quarter of 1.01. Closing backlog of $24.7 billion, an increase of 0.3% on quarter four 2024 and 6.0% on quarter one 2024.

What is the current share price of ICON plc (ICLR)? ICON plc's (ICLR) current share price is $175.21. This constitutes a price movement of 1.36% when compared to the share price 7 days ago and is ...

DUBLIN - ICON plc (NASDAQ: ICLR), a global provider of outsourced development services to the pharmaceutical, biotechnology, and medical device industries, has announced the appointment of Nigel ...